Mettler-Toledo International, Inc. Common Stock (MTD)
1,056.58
-13.99 (-1.31%)
NYSE · Last Trade: May 1st, 11:26 PM EDT
Detailed Quote
Previous Close
1,070.57
Open
1,074.13
Bid
425.46
Ask
1,354.70
Day's Range
1,029.23 - 1,077.82
52 Week Range
946.69 - 1,546.93
Volume
248,513
Market Cap
25.14B
PE Ratio (TTM)
26.09
EPS (TTM)
40.5
Dividend & Yield
N/A (N/A)
1 Month Average Volume
259,470
Chart
About Mettler-Toledo International, Inc. Common Stock (MTD)
Mettler-Toledo International is a global leader in precision instruments and weighing systems, providing innovative solutions to a wide range of industries including food, pharmaceuticals, and laboratories. The company specializes in high-quality analytical and measuring instruments, which facilitate accurate measurements in various applications, from manufacturing processes to scientific research. Mettler-Toledo is committed to enhancing productivity, ensuring compliance with regulatory standards, and achieving exceptional measurement accuracy, thereby supporting its customers in optimizing their operations and improving overall efficiency. The company also offers comprehensive services, including calibration and maintenance, ensuring that its clients receive optimal performance from their equipment. Read More
Precision measurement company Mettler-Toledo (NYSE:MTD) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 4.6% year on year to $883.7 million. Its non-GAAP profit of $8.19 per share was 3.9% above analysts’ consensus estimates.
Precision measurement company Mettler-Toledo (NYSE:MTD)
will be announcing earnings results tomorrow after market hours. Here’s what investors should know.
Mettler-Toledo International Inc. (NYSE:MTD) today announced it will present at the BofA Securities 2025 Healthcare Conference on Wednesday, May 14, 2025, at 4:20pm Pacific Time (7:20pm Eastern Time). A live webcast of the presentation will be available on the Company’s investor relations website at investor.mt.com.
Wall Street pushed higher in midday trading, with the S&P 500 on track for its eighth consecutive gain — its longest winning streak since November 2023. The index rose about 1% to 5,560, fully recovering the losses sustained after former President Donald Trump announced trade tariffs on April 2.
While profitability is essential, it doesn’t guarantee long-term success.
Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my opportunity".
Wondering which stocks are making significant price gaps? Explore the S&P500 index on Wednesday to find the gap up and gap down stocks in today's session.
Let’s dig into the relative performance of Avantor (NYSE:AVTR) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.
Let’s dig into the relative performance of Mettler-Toledo (NYSE:MTD) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.
Mettler-Toledo International Inc. (NYSE: MTD) announced it will release its first quarter 2025 financial results after the market close on Thursday, May 1, 2025. The Company will host a conference call the following morning at 8:30 a.m. Eastern Time to discuss the results. To listen to the live audio webcast of the call, visit Events and Presentations on the Investor section of the Company’s website, investor.mt.com.
Let’s dig into the relative performance of Bio-Techne (NASDAQ:TECH) and its peers as we unravel the now-completed Q4 research tools & consumables earnings season.
As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the research tools & consumables industry, including Waters Corporation (NYSE:WAT) and its peers.
Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at PacBio (NASDAQ:PACB) and its peers.
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets.
But the many opportunities in front of them attract significant competition, spanning from industry behemoths with seemingly infinite resources to small, nimble players with chips on their shoulders.
Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Thermo Fisher (NYSE:TMO) and its peers.
